Periodontal therapy and systemic inflammation in type 2 diabetes mellitus: a meta-analysis.

<h4>Aim</h4>The aim of this systematic review was to assess the effect of periodontal therapy (PT) on serum levels of inflammatory markers in people with type 2 diabetes mellitus (T2DM).<h4>Methods of study selection</h4>A literature search was carried out using MEDLINE via P...

Full description

Bibliographic Details
Main Authors: Hilana Paula Carillo Artese, Adriana Moura Foz, Mariana de Sousa Rabelo, Giovane Hisse Gomes, Marco Orlandi, Jean Suvan, Francesco D'Aiuto, Giuseppe Alexandre Romito
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0128344
id doaj-c02140a3c53f463c920a7688d1d22bb3
record_format Article
spelling doaj-c02140a3c53f463c920a7688d1d22bb32021-03-04T08:06:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01105e012834410.1371/journal.pone.0128344Periodontal therapy and systemic inflammation in type 2 diabetes mellitus: a meta-analysis.Hilana Paula Carillo ArteseAdriana Moura FozMariana de Sousa RabeloGiovane Hisse GomesMarco OrlandiJean SuvanFrancesco D'AiutoGiuseppe Alexandre Romito<h4>Aim</h4>The aim of this systematic review was to assess the effect of periodontal therapy (PT) on serum levels of inflammatory markers in people with type 2 diabetes mellitus (T2DM).<h4>Methods of study selection</h4>A literature search was carried out using MEDLINE via Pubmed, EMBASE, LILACS and Cochrane Central Register of Controlled Trials (CENTRAL) databases. Randomized-controlled trials (RCTs) and controlled clinical trials (CCTs) evaluating the effect of PT on systemic inflammatory markers were deemed eligible. Case series (CS), reports and pilot trials were excluded. Study quality was assessed using the Cochrane Collaboration's risk assessment tool. Meta-analysis was carried out using random effect methods.<h4>Results</h4>The search strategy identified 3,164 potential studies of which 61 were assessed for eligibility and 9 (6 RCTs and 3 CCTs) were included in this systematic review. Three RCTs were classified by the authors as being at low risk of bias and three were "unclear" and classified as uncertain risk of bias. All CCTs were considered to be at a high risk of bias. The meta-analysis showed a statistically significant mean difference (MD) for TNF- α (-1.33 pg/ml, 95% CI: -2.10; -0.56, p<0.001) and CRP (-1.28 mg/l, 95% CI: -2.07; - 0.48, p<0.001) favoring periodontal intervention versus control.<h4>Conclusion</h4>The results of this meta-analysis support the hypothesis that PT reduces serum levels of TNF- α and CRP in T2DM individuals. The decrease of inflammatory burden has important implications for metabolic control and can, in part, explain the mechanisms linking periodontitis and increased risk for complications in people with T2DM.https://doi.org/10.1371/journal.pone.0128344
collection DOAJ
language English
format Article
sources DOAJ
author Hilana Paula Carillo Artese
Adriana Moura Foz
Mariana de Sousa Rabelo
Giovane Hisse Gomes
Marco Orlandi
Jean Suvan
Francesco D'Aiuto
Giuseppe Alexandre Romito
spellingShingle Hilana Paula Carillo Artese
Adriana Moura Foz
Mariana de Sousa Rabelo
Giovane Hisse Gomes
Marco Orlandi
Jean Suvan
Francesco D'Aiuto
Giuseppe Alexandre Romito
Periodontal therapy and systemic inflammation in type 2 diabetes mellitus: a meta-analysis.
PLoS ONE
author_facet Hilana Paula Carillo Artese
Adriana Moura Foz
Mariana de Sousa Rabelo
Giovane Hisse Gomes
Marco Orlandi
Jean Suvan
Francesco D'Aiuto
Giuseppe Alexandre Romito
author_sort Hilana Paula Carillo Artese
title Periodontal therapy and systemic inflammation in type 2 diabetes mellitus: a meta-analysis.
title_short Periodontal therapy and systemic inflammation in type 2 diabetes mellitus: a meta-analysis.
title_full Periodontal therapy and systemic inflammation in type 2 diabetes mellitus: a meta-analysis.
title_fullStr Periodontal therapy and systemic inflammation in type 2 diabetes mellitus: a meta-analysis.
title_full_unstemmed Periodontal therapy and systemic inflammation in type 2 diabetes mellitus: a meta-analysis.
title_sort periodontal therapy and systemic inflammation in type 2 diabetes mellitus: a meta-analysis.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description <h4>Aim</h4>The aim of this systematic review was to assess the effect of periodontal therapy (PT) on serum levels of inflammatory markers in people with type 2 diabetes mellitus (T2DM).<h4>Methods of study selection</h4>A literature search was carried out using MEDLINE via Pubmed, EMBASE, LILACS and Cochrane Central Register of Controlled Trials (CENTRAL) databases. Randomized-controlled trials (RCTs) and controlled clinical trials (CCTs) evaluating the effect of PT on systemic inflammatory markers were deemed eligible. Case series (CS), reports and pilot trials were excluded. Study quality was assessed using the Cochrane Collaboration's risk assessment tool. Meta-analysis was carried out using random effect methods.<h4>Results</h4>The search strategy identified 3,164 potential studies of which 61 were assessed for eligibility and 9 (6 RCTs and 3 CCTs) were included in this systematic review. Three RCTs were classified by the authors as being at low risk of bias and three were "unclear" and classified as uncertain risk of bias. All CCTs were considered to be at a high risk of bias. The meta-analysis showed a statistically significant mean difference (MD) for TNF- α (-1.33 pg/ml, 95% CI: -2.10; -0.56, p<0.001) and CRP (-1.28 mg/l, 95% CI: -2.07; - 0.48, p<0.001) favoring periodontal intervention versus control.<h4>Conclusion</h4>The results of this meta-analysis support the hypothesis that PT reduces serum levels of TNF- α and CRP in T2DM individuals. The decrease of inflammatory burden has important implications for metabolic control and can, in part, explain the mechanisms linking periodontitis and increased risk for complications in people with T2DM.
url https://doi.org/10.1371/journal.pone.0128344
work_keys_str_mv AT hilanapaulacarilloartese periodontaltherapyandsystemicinflammationintype2diabetesmellitusametaanalysis
AT adrianamourafoz periodontaltherapyandsystemicinflammationintype2diabetesmellitusametaanalysis
AT marianadesousarabelo periodontaltherapyandsystemicinflammationintype2diabetesmellitusametaanalysis
AT giovanehissegomes periodontaltherapyandsystemicinflammationintype2diabetesmellitusametaanalysis
AT marcoorlandi periodontaltherapyandsystemicinflammationintype2diabetesmellitusametaanalysis
AT jeansuvan periodontaltherapyandsystemicinflammationintype2diabetesmellitusametaanalysis
AT francescodaiuto periodontaltherapyandsystemicinflammationintype2diabetesmellitusametaanalysis
AT giuseppealexandreromito periodontaltherapyandsystemicinflammationintype2diabetesmellitusametaanalysis
_version_ 1714808066403205120